Lab-Grown Organoids Advance Research on Human Brain Development and Disease
Researchers use lab-grown organoids to model human brain development and study diseases. These three-dimensional structures mimic brain tissue and enable detailed analysis of cellular processes. The approach provides insights into conditions such as microcephaly and Zika virus effects.
Korinna / Wikimedia (CC BY 4.0)Lab-grown organoids, which are three-dimensional structures derived from human stem cells, are used to study brain development and related diseases. These organoids replicate aspects of brain tissue organization and function. Scientists reported on their application in a recent article in Nature.
Organoids allow researchers to observe brain development in a controlled environment. They form neural structures similar to those in human embryos. This method facilitates the examination of genetic and environmental factors influencing brain growth.
Studies have applied organoids to investigate neurodevelopmental disorders. For example, researchers modeled microcephaly, a condition involving reduced brain size, using patient-derived cells. The organoids revealed disruptions in neural progenitor cell proliferation.
Applications in Disease Modeling Organoids have been used to study the impact of Zika virus on brain development.
Infected organoids showed reduced growth and increased cell death, mirroring effects observed in affected fetuses. This approach helps identify potential therapeutic targets. The technology also aids in understanding autism spectrum disorders and schizophrenia.
By comparing organoids from healthy and diseased individuals, researchers identify differences in gene expression and cell connectivity. These findings contribute to broader knowledge of brain function.
Future Research Directions Ongoing work focuses on improving organoid complexity to better simulate the full brain.
Challenges include vascularization and integration of multiple cell types. Advances in this area could enhance drug testing and personalized medicine approaches. Researchers emphasize the ethical considerations of using human-derived tissues.
Guidelines ensure responsible use in studies. The method remains a key tool for non-invasive brain research.
Story Timeline
3 events- Recent publication
Nature publishes article on lab-grown organoids for brain research.
1 source@Nature - Ongoing studies
Researchers apply organoids to model Zika virus effects on brain development.
1 source@Nature - Prior developments
Organoids developed to study microcephaly and other neurodevelopmental disorders.
1 source@Nature
Potential Impact
- 01
Improved models support more accurate drug testing for brain diseases.
- 02
Organoids enable identification of new therapeutic targets for neurodevelopmental disorders.
- 03
Research advances contribute to understanding of genetic factors in brain development.
- 04
Ethical guidelines shape future use of human-derived tissues in labs.
Transparency Panel
Related Stories
NASA Johnson Space Center / Wikimedia (Public domain)NASA's Artemis II Completes First Manned Moon Mission Since 1972, Sets Distance Record
NASA's Artemis II mission completed a flight around the moon and splashed down in the Pacific Ocean on Saturday. The mission marks the first manned moon mission since 1972 and set a record for the furthest humans have travelled into space at 252,756 miles (406,771km). Meanwhile,…
Science NewsNearly 1 in 5 Gray Whales Entering San Francisco Bay Die There, Study Finds
Researchers report that approximately 18 percent of photo-identified gray whales visiting San Francisco Bay from 2018 to 2025 died after entering the area. The deaths, often from vessel strikes, coincide with a population decline linked to reduced Arctic food availability. The fi…
StatSpyre Therapeutics' SPY001 Drug Meets Primary Goal in Phase 2 Ulcerative Colitis Trial
Spyre Therapeutics announced positive results from the first batch of data in its Phase 2 SKYLINE study for SPY001, an experimental treatment for ulcerative colitis. The drug achieved a 9.2-point decrease in disease activity and induced remission in about 40% of participants afte…